about
Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulationThe allele encoding the mycobacterial Erp protein affects lung disease in miceRespiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma/COPDRab27a-mediated protease release regulates neutrophil recruitment by allowing uropod detachmentA role for Na+,K+-ATPase α1 in regulating Rab27a localisation on melanosomes.Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.Novel functions for Rab GTPases in multiple aspects of tumour progression.The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA.Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design.Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression.MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.Correction: A Role for Na+,K+-ATPase α1 in Regulating Rab27a Localisation on Melanosomes.Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.Distinct and opposing roles for Rab27a/Mlph/MyoVa and Rab27b/Munc13-4 in mast cell secretionV-ATPase: a potential pH sensorSignal-sequence-independent secretion of the staphylococcal nuclease in Mycobacterium smegmatisAnthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophagesThe tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerInactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
P50
Q28486629-13CECA7A-91FA-4081-ACF2-4F5D67DE74DAQ28486728-A5952745-211A-4DE8-B31D-AAB45139826CQ28540152-023C5D73-1EF4-4092-B9DA-4ED118C4B001Q30513978-7D29D0A6-4D8A-47C1-8C32-DB927161F873Q33933426-7C665D74-1144-4B20-AF36-6E7751F4A76CQ34468644-559D870C-0F58-4BFA-A8FC-0B71E7703481Q36559474-E97331AB-C106-4F2F-BC0E-420564444859Q36718374-938589C4-F4F6-494D-983F-A4D55559F9B4Q37353982-C5C2050E-030A-411E-AD20-1E42B148D5ABQ38929132-6635241B-DADD-40ED-95C2-BF3E92D203A3Q39302103-C092A77F-BED6-44B5-A44D-A8C06CDF4515Q39969514-D9CE3157-7710-4592-90ED-3D188453E39FQ41016601-CAEB7A81-5607-4E3A-8DF6-A05E047D0155Q42550033-FAD44DF8-8A43-41AB-B0C8-CA3EE21C5E35Q45870013-14F3AE0A-52AD-49B1-8192-24F645FF4DCBQ51146366-F16E7F2A-6A95-4396-A719-76E7BD69B361Q60042781-6C1872DA-87E5-48A4-8714-4C5BE125BD33Q64019143-AC8D0AE2-627F-457E-A6E0-123E43262ED2Q64019144-F4EE29F1-1C45-4DFE-B326-853A17A1160EQ64019145-4C9E0970-8E2C-4223-AD16-7ED58CFD5FE7Q89121009-A48CDAEC-3543-4EBD-A643-D233C3A914D6Q91968180-926430FE-502F-4D71-9A2A-4D5C4A6A7142
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chiara Recchi
@ast
Chiara Recchi
@en
Chiara Recchi
@es
Chiara Recchi
@nl
type
label
Chiara Recchi
@ast
Chiara Recchi
@en
Chiara Recchi
@es
Chiara Recchi
@nl
prefLabel
Chiara Recchi
@ast
Chiara Recchi
@en
Chiara Recchi
@es
Chiara Recchi
@nl
P106
P21
P31
P496
0000-0003-1605-0945